-
Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023
Sep 9, 2025, 16:22 PM -
Comparator Misalignment As a Contributor to Negative Reimbursement Decisions for Pharmaceuticals in Sweden
Sep 9, 2025, 16:22 PM -
Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression
Sep 9, 2025, 16:22 PM -
Evaluating the Performance of an Artificial Intelligence A-Powered Tool for Assessing Quality of Published Economic Evaluations: A Comparison With Human Reviewers Using the Drummond Checklist
Sep 9, 2025, 16:22 PM -
Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
Sex Differences in Patients With Chronic Hand Eczema (CHE): Disease Manifestations and Quality of Life (QoL) Results From a Cross-Sectional Multinational Study
Sep 9, 2025, 16:22 PM -
Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial
Sep 9, 2025, 16:22 PM -
Analysis of Social and Economic Burden of Type 1 Diabetes Care in Italy
Sep 9, 2025, 16:22 PM -
Ten Years of Portugal’s HTA System Through Stakeholder Eyes: Reflections and Future Priorities
Sep 9, 2025, 16:22 PM -
Improving Colorectal Cancer Surgical Outcomes Through Audit and Feedback: Results From the Emilia Romagna ESCA Program
Sep 9, 2025, 16:22 PM -
A Person-Centered Approach: Exploring Social Support Network and Mental Health Among Shoebox House Residents in Hong Kong
Sep 9, 2025, 16:22 PM -
Guidelines for Health Technology Assessment Ministry of Health Sultanate of Oman
Sep 9, 2025, 16:22 PM -
Measuring Health-Related Quality of Life and Food Insecurity in the General Population in Lebanon During the Third Worst Socioeconomic Crisis in History
Sep 9, 2025, 16:22 PM -
Correlation of Intermediate Clinical Endpoints (ICES) For Overall Survival (OS) In Localized or Locally Advanced Prostate Cancer (LPC/LAPC): Analysis of Individual Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes
Sep 9, 2025, 16:22 PM -
Societal and Economic Burden of Obesity in Bulgaria
Sep 9, 2025, 16:22 PM -
Price Implications of the Most-Favored Nation Policy on US Oncology Drug Prices
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies
Sep 9, 2025, 16:22 PM -
Rising Costs in Pharmaceutical Services: A Decade of Prescription Spending Trends in Türkiye 2015-2024
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Patients With Non-Small Cell Lung Cancer (NSCLC) and Epidermal Growth Factor Receptor Mutation (eGFRm): A Retrospective Cohort Study in a Portuguese Comprehensive Cancer Center
Sep 9, 2025, 16:22 PM
